What is Thymosin Alpha-1 and how does it work?

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide naturally produced by the thymus gland. It works by enhancing T-cell maturation, activating dendritic cells through Toll-like receptor (TLR) signaling, increasing natural killer cell activity, and modulating cytokine production. As the thymus shrinks with age (thymic involution), natural Tα1 production declines, making supplementation increasingly relevant for maintaining immune function.

What are the benefits of Thymosin Alpha-1 for immunity?

Thymosin Alpha-1 benefits include: enhanced T-cell production and maturation, improved CD4/CD8 T-cell ratios, increased NK cell cytotoxicity, better dendritic cell antigen presentation, modulation of inflammatory cytokines (reducing chronic inflammation), improved vaccine response in elderly/immunocompromised individuals, and support for immune surveillance against infections and abnormal cells.

Is Thymosin Alpha-1 FDA approved?

Thymosin Alpha-1 has FDA orphan drug designation for hepatitis B treatment in the United States. It is approved as a pharmaceutical (marketed as Zadaxin) in over 35 countries for hepatitis B/C treatment and as an immune adjuvant. In the US, it

What is the standard Thymosin Alpha-1 dosage?

The standard clinical dosage is 1.6mg administered subcutaneously twice weekly (every 3-4 days). Some protocols use daily dosing of 1.6mg for acute immune challenges, then transition to twice weekly for maintenance. For research purposes, doses range from 0.8mg to 3.2mg depending on the protocol. Most clinical trials have used the 1.6mg twice-weekly regimen.

Can Thymosin Alpha-1 help with aging immune function?

Yes. Immunosenescence—the decline of immune function with age—is driven largely by thymic involution, which reduces T-cell output. Thymosin Alpha-1 directly counteracts this by promoting T-cell maturation, restoring T-cell diversity, and enhancing immune surveillance. Studies in elderly populations show improved vaccine responses and restored immune parameters after Tα1 treatment.

What is the difference between Thymosin Alpha-1 and Thymosin Beta-4?

Despite similar names, these are different peptides with different functions. Thymosin Alpha-1 (28 amino acids) is an immune modulator that enhances T-cell function and immune surveillance. Thymosin Beta-4 (TB-500, 43 amino acids) is involved in tissue repair, wound healing, and anti-inflammatory effects. They come from the same thymus gland but serve distinct biological roles.

Are there side effects with Thymosin Alpha-1?

Thymosin Alpha-1 has an excellent safety profile across decades of clinical use. The most common side effect is mild injection site irritation. Because it modulates rather than stimulates the immune system, it rarely causes immune overactivation. However, individuals with autoimmune conditions should use it under medical supervision, as enhanced immune function could theoretically worsen autoimmune responses.

PeptideKey Research Library

Thymosin Alpha-1: 76 Human Studies — 75% T-cell Boost

Explore Thymosin Alpha-1 peptides for longevity. Our evidence-based guide covers TA1's immune benefits & research. Unlock your potential!

This research guide is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.